Paris, France

Christophe Pacaud

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Paris, FR (2013 - 2014)
  • Cachan, FR (2016)

Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Christophe Pacaud

Introduction

Christophe Pacaud is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. With a total of 3 patents to his name, Pacaud's work is recognized for its potential therapeutic applications.

Latest Patents

Pacaud's latest patents include innovative compounds such as 3,4-dihydropyrrolo[1,2-A]pyrazine-2,8(1H)-dicarboxamide derivatives. These compounds are designed for therapeutic use in diseases involving casein kinase 1 epsilon and/or casein kinase 1 delta. The compounds correspond to a general formula where R represents various alkyl and cycloalkyl groups, and X can be hydrogen, fluorine, chlorine, or bromine atoms. This innovative approach highlights Pacaud's commitment to advancing medical science.

Career Highlights

Christophe Pacaud is currently employed at Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to focus on the development of new therapeutic agents that can address complex health issues. Pacaud's expertise in medicinal chemistry has been instrumental in his success as an inventor.

Collaborations

Throughout his career, Pacaud has collaborated with esteemed colleagues such as Frederic Puech and Jacques Froissant. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their shared research goals.

Conclusion

Christophe Pacaud's contributions to the field of pharmaceuticals through his patents and collaborations demonstrate his dedication to innovation. His work continues to have a significant impact on the development of new therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…